Work ability following breast cancer – the MyHealth randomized controlled trial
Authors:
- Trine A. HorsbølTHTrine A. Horsbøl
- Lena SaltbækLSLena Saltbæk
- Randi V. KarlsenRKRandi V. Karlsen
- Christoffer JohansenCJChristoffer Johansen
- Pernille E. BidstrupPBPernille E. Bidstrup
- Beverley L. HøegBHBeverley L. Høeg
- Vibeke ZoffmannVZVibeke Zoffmann
- Federica BelmonteFBFederica Belmonte
- Ingelise AndersenIAIngelise Andersen
- Anne S. FribergAFAnne S. Friberg
- Mads N. SvendsenMSMads N. Svendsen
Open Access
- 8 January 2025
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 64, 34-39
Abstract
Background and purpose: We previously demonstrated positive effects on quality of life and mental health following breast cancer when comparing a nurse-led follow-up program without scheduled visits (MyHealth) to regular follow-up. This study aims to examine whether MyHealth also positively impacts self-reported work ability. Patients/material and methods: A total of 288 patients, potentially active on the labour market, were randomized to MyHealth or control follow-up after primary treatment for early-stage breast cancer (2017–2019). MyHealth included individual self-management sessions, electronic symptom monitoring, and assistance with navigating healthcare services. Control follow-up consisted of biannual outpatient visits with a physician. Linear mixed-effect models were applied to evaluate the effect of MyHealth on self-reported work ability at 6, 12, 24, and 36 months after randomization as measured by the Work Ability Score (WAS). Results: Work ability increased significantly in both groups during the first 6 months (mean WAS increase MyHealth: 1.64, 95% confidence interval [CI]: 1.26; 2.02 and control: 1.57, 95% CI: 1.17; 1.97) and continued to increase slightly but non-significantly (p-values > 0.13) until end of follow-up at 36 months. Improvement was especially pronounced among patients reporting poor work ability at baseline. Differences in mean WAS between patients in MyHealth and control follow-up were non-significant and close to zero at all time points (–0.21 to 0.48). Interpretation: The MyHealth follow-up program had no additional effect on self-reported work ability compared to regular follow-up. Future interventions should target patients with poor work ability and include components specifically designed to enhance work ability.Keywords
This publication has 26 references indexed in Scilit:
- Non-medical interventions to enhance return to work for people with cancerCochrane Database of Systematic Reviews, 2024
- Work ability 8 years after breast cancer: exploring the role of social support in a nation-wide surveyBreast Cancer Research and Treatment, 2022
- Experiences of women with breast cancer while working or returning to work: a qualitative systematic review and meta-synthesisSupportive Care in Cancer, 2021
- The role of depression and other psychological factors in work ability among breast cancer survivors in AustraliaPsycho-Oncology, 2021
- The development and initial validation of the Breast Cancer Recurrence instrument (BreastCaRe)—a patient-reported outcome measure for detecting symptoms of recurrence after breast cancerQuality of Life Research, 2021
- Long-term work retention after treatment for cancer: a systematic review and meta-analysisJournal of Cancer Survivorship, 2020
- Return to work after a cancer diagnosis: a meta-review of reviews and a meta-synthesis of recent qualitative studiesJournal of Cancer Survivorship, 2019
- Changes in importance of work and vocational satisfaction during the 2 years after breast cancer surgery and factors associated with thisJournal of Cancer Survivorship, 2015
- Physical and psychosocial problems in cancer survivors beyond return to work: a systematic reviewPsycho-Oncology, 2013
- Work ability of survivors of breast, prostate, and testicular cancer in Nordic countries: a NOCWO studyJournal of Cancer Survivorship, 2011